Cytosorbents (CTSO) Common Equity (2010 - 2026)
Cytosorbents' (CTSO) quarterly Common Equity came in at $2.2 million in Q1 2026, down 84.91% YoY from $14.5 million in Q1 2025, and down 62.83% on a QoQ basis from $5.9 million in Q4 2025.
Cytosorbents (CTSO) Common Equity (2010 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 17 years of Common Equity data on file, last reported at $2.2 million in Q1 2026.
- Quarterly Common Equity fell 84.91% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 million (down 84.91% YoY) and the FY2025 annual result came in at $5.9 million, down 46.85% from the prior year.
- Common Equity fell to $2.2 million in Q1 2026, from $5.9 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $55.4 million in Q1 2022 to a low of $2.2 million in Q1 2026.
- A 5-year average of $22.3 million and a median of $18.8 million in 2023 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2025 — Common Equity fell 25.89% — and 2026, when it sank 84.91%.
- Tracing CTSO's Common Equity over 5 years: stood at $35.4 million in 2022, then slumped by 33.63% to $23.5 million in 2023, then plunged by 52.7% to $11.1 million in 2024, then plunged by 46.85% to $5.9 million in 2025, then tumbled by 62.83% to $2.2 million in 2026.
- The last three Common Equity figures came in at $2.2 million (Q1 2026), $5.9 million (Q4 2025), and $9.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 23.99 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 10.72 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.62 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.99 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 13.31 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Cytosorbents | 19.47 Mn | 15.06 Mn | 7.05 Mn | -751,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -751,000.00 |
| Mar 31, 2026 | 2.19 Mn |
| Dec 31, 2025 | 5.90 Mn |
| Sep 30, 2025 | 9.02 Mn |
| Jun 30, 2025 | 11.59 Mn |
| Mar 31, 2025 | 14.54 Mn |
| Dec 31, 2024 | 11.11 Mn |
| Sep 30, 2024 | 13.38 Mn |
| Jun 30, 2024 | 17.43 Mn |
| Mar 31, 2024 | 19.63 Mn |
| Dec 31, 2023 | 23.48 Mn |
| Sep 30, 2023 | 18.81 Mn |
| Jun 30, 2023 | 24.46 Mn |
| Mar 31, 2023 | 29.94 Mn |
| Dec 31, 2022 | 35.37 Mn |
| Sep 30, 2022 | 39.14 Mn |
| Jun 30, 2022 | 47.56 Mn |
| Mar 31, 2022 | 55.43 Mn |
| Dec 31, 2021 | 62.58 Mn |
| Sep 30, 2021 | 70.61 Mn |